1. C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma. (5th June 2019) Authors: Nassiri, F; Mamatjan, Y; Suppiah, S; Badhiwala, J; Mansouri, S; Karimi, S; Saarela, O; Poisson, L; Ng, H; Noushmehr, H; Harter, P; Baumgarten, P; Weller, M; Preusser, M; Mende, C; Sahm, F; von Deimling, A; Aldape, K; Zadeh, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Born in weak fields: below-threshold photoelectron dynamics. (13th January 2017) Authors: Williams, J B; Saalmann, U; Trinter, F; Schöffler, M S; Weller, M; Burzynski, P; Goihl, C; Henrichs, K; Janke, C; Griffin, B; Kastirke, G; Neff, J; Pitzer, M; Waitz, M; Yang, Y; Schiwietz, G; Zeller, S; Jahnke, T; Dörner, R Journal: Journal of physics Issue: Volume 50:Number 3(2017:Feb. 01) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. (10th April 2018) Authors: Wirsching, H -G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, L; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tumor-treating fields: time for demystification. (14th June 2018) Authors: Weller, M Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. (30th March 2018) Authors: Gramatzki, D; Roth, P; Rushing, E J; Weller, J; Andratschke, N; Hofer, S; Korol, D; Regli, L; Pangalu, A; Pless, M; Oberle, J; Bernays, R; Moch, H; Rohrmann, S; Weller, M Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P05.28 Karnofsky performance score of brain tumor patients depends on clinician status. (19th September 2018) Authors: Frappaz, D; Taillandier, L; Levard-Bonneville, A; Sore, J; Ricard, D; Schiffler, C; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P05.28 Karnofsky performance score of brain tumor patients depends on clinician status. (19th September 2018) Authors: Frappaz, D; Taillandier, L; Levard-Bonneville, A; Sore, J; Ricard, D; Schiffler, C; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OS2.1 Objective responses to chemotherapy in recurrent glioma do not predict better survival: A prospective analysis from the German Glioma Network. (19th September 2018) Authors: Bähr, O; Hentschel, B; Hattingen, E; Reusche, M; Tatagiba, M; Tonn, J; Schnell, O; Schackert, G; Westphal, M; Herrlinger, U; Pietsch, T; Reifenberger, G; Weller, M; Löffler, M; Steinbach, J P Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗